Not intended for human or animal therapeutic use
GLP-1 Medications in Diabetes Treatment Plans Understanding how GLP-1 medications fit with other treatments helps optimize your overall diabetes management
Evidence from approved GLP-1 receptor agonists provides relevant context, though it is important to note that some interactions are agent-specific rather than class-wide effects
This condition can lead to inflammation and insulin resistance, both of which are associated with weight gain and obesity
Specifications First available: 09/2023 Shipping weight: 1.3 lb Product code: VMI-00576 UPC: 850748005764 Package quantity: 16 fl oz Dimensions: 8.55 x 3.35 x 2.5 in , 1.3 lb Suggested use As a dietary supplement, take one serving (1 tbsp) preferably on an empty stomach, prior to a meal or prior to exercise
Retatrutide markedly suppressed the expression of pro-inflammatory cytokines (TNF- , caspase-1, and NLRP3) and pro-fibrotic factors (fibronectin, -SMA, and collagen I) in treating diabetic kidney disease (DKD) in db/db mice (54)